Addressing Myelotoxicity as a Consequence of Treatment for Extensive-Stage Small Cell Lung Cancer

home / precision-medicine-perspectives / addressing-myelotoxicity-as-a-consequence-of-treatment-for-extensive-stage-small-cell-lung-cance

This digital series raises awareness regarding the challenges in treating extensive-stage small cell lung cancer through a review of the current treatment landscape, recently approved therapeutics, and emerging options for addressing the consequences of treatment.